AlphAIalphai — Financial news for AI agents
SEC EDGARAUG 251 min read$TWST

Green Paula sold $189K of TWST

Green Paula (SVP of Human Resources) sold 1,360 shares of Twist Bioscience Corp (TWST) at $139.07 ($0.19M total) on 2026-08-21.

Original reporting
SEC EDGAR · Green Paula
Published Aug 25, 2026, 8:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 25, 2026, 8:11 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$TWST
Neutral
high confidence
Mentioned
$TWST
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TWSTNeutralLow
01

Why it matters

The disclosed sale is routine and unlikely to affect stock valuation.

02

Market read

Limited relevance; typical insider sell with modest monetary value.

03

What to watch

Potential upcoming corporate actions or performance issues not yet disclosed.

Relevance 4/10Novelty 4/10Timing: post-filing 2026-08-25

Background

Twist Bioscience is a synthetic DNA manufacturer; insider transactions are regularly reported via Form 4.

Company-level read

Ticker impact

$TWSTNeutralHigh confidence
Context

Form 4 disclosed SVP of HR sold 1,360 shares for $189K, reducing holdings to 117,921 shares.

Expected impact

No significant impact; potential slight downward pressure.

Evidence & confidence

Sale size is modest relative to float and insider ownership; no broader implications.

Market effects

Sector

None; HR executive sale does not affect biotech sector.

Regional

None; limited to US market where TWST trades.

Global

Minimal; isolated insider transaction.

Counterpoint

What could challenge this read

Even small insider sells can signal concerns; monitor for further disposals.

Key entities

  • Individual
    Green Paula

    SVP of Human Resources at Twist Bioscience, reported insider sale.

  • Company
    Twist Bioscience Corp

    Biotech company (ticker TWST) subject of the insider transaction.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

TWST insider trading history →

Related articles

AUG 23
$MRNAHighAI 9/10

Bond Jitters Meet Biotech Fireworks

Bond market volatility pressured stocks early in the week, with the Nasdaq dropping 2.1%. Biotech stocks surged: Moderna (MRNA) rose 177% after positive cancer trial results, and Twist Bioscience (TWST) gained 23% on AI-driven protein binder success. NVIDIA's earnings and the Jackson Hole symposium are upcoming market tests.

zerohedge.com3 min
AUG 21
$TWSTHighAI 8/10

Twist Bioscience Stock Surges As Anthropic AI Deal And Upbeat Guidance Reset Outlook

Twist Bioscience (TWST) stock rose 6.79% on strong investor optimism. The company reported Q3 revenue of $118.4M, up 23% YoY, with a 78% gross margin but negative EBIT margin and ROE. Guidance was raised to $456M-$457M for FY26, with Q4 adjusted EBITDA breakeven expected. The stock has seen strong technical performance, with resistance near $150 and support at $130-$135.

stockstotrade.com2 min
AUG 19
$TWSTHighAI 8/10

Why is Twist Bioscience stock surging today?

Twist Bioscience (TWST) stock rose 15.3% after Anthropic's research highlighted its role in producing AI-designed proteins. The company filed an 8-K disclosing the collaboration, which supports its AI-driven drug discovery growth narrative. Shares reached a 52-week high of $141.10.

investing.com2 min